Duran-Castells, C., Llano, A., Kawana-Tachikawa, A., Prats, A., Martinez-Zalacain, I., Kobayashi-Ishihara, M., . . . Ruiz Riol, M. (2023). Sirtuin-2, NAD-Dependent Deacetylase, is a new potential therapeutic target for HIV-1 infection and HIV-related neurological dysfunction.
Citación estilo ChicagoDuran-Castells, Clara, et al. Sirtuin-2, NAD-Dependent Deacetylase, Is a New Potential Therapeutic Target for HIV-1 Infection and HIV-related Neurological Dysfunction. 2023.
Cita MLADuran-Castells, Clara, et al. Sirtuin-2, NAD-Dependent Deacetylase, Is a New Potential Therapeutic Target for HIV-1 Infection and HIV-related Neurological Dysfunction. 2023.
Precaución: Estas citas no son 100% exactas.